- The journal
- nike outlets have jordans
- NIKE AIR JORDAN 4 RETRO KAWS GREY 26.5cm , Fenua-environnementShops , Blue Jordan See What Air Jordans are Releasing April 2016
- Cheap Rcj Jordan Outlet - choice jordan True Flight Bordeaux - Michael Beasley right defending in the Flint Grey Air choice jordan 7
- Axel Arigato Men's Bird Tape Sneakers in Cremino, women and kids • Hanbags and accessories
- Cartier Trinity Wrist Watch 254085 , FonjepShops
- adidas yeezy 700 v3 fade carbon GW1814 fadcar release date
- buy nike dunk low purple pulse dm9467 500 shoes online
- adidas originals yeezy boost 350 v2 core blackred
- Air Jordan 1 Heritage 555088 161 Release Date On Foot
- buy air jordan 1 twist panda cd0461 007 store list
- Aims & Scope
- Editorial Policies and Processes
- Scientific and Methodological Rigor
- Production and Administration
- Committees
- Authors
- Ethical Considerations
- Submit Article
- Archive
- Indexation
- Search
- Contact us
Farm Comunitarios. 17(1):5-10. doi: 10.33620/FC.2173-9218.(2025).02
Anticholinergic burden in the elderly
Rodríguez M. Anticholinergic burden in the elderly. Farm Comunitarios. 17(1):5-10. doi: 10.33620/FC.2173-9218.(2025).02
Abstract :
Anticholinergic drugs are widely used for very common diseases such as Parkinson’s disease, depression or allergies, but it has been observed in previous studies that high anticholinergic burden can lead to physical and cognitive dysfunctions in polymedicated elderly people. The objective of this project is to review these
hypotheses and study the possible relationship between high anticholinergic burden and cognitive and physical dysfunctions.
In terms of methodology, a bibliographic review has been carried out of the information that exists to date on the hypothesis that high anticholinergic burden can lead to both physical and cognitive dysfunctions in elderly people taking multiple medications, and a cross-sectional study has been designed that included patients over 70 years and taking multiple medications to calculate the anticholinergic burden of their medication and determine whether high levels of it could have any influence on the deterioration of the patients.
At the end of the study, it was observed high prevalence of prescriptions of medications with high anticholinergic burden in elderly patients, with its consequences in terms of adverse effects. These results lead us to the conclusion of the need to take into account the anticholinergic burden of medications when prescribing.
Keywords :
Anticholinergic, aged, cognitive, dysfunction
Article download link:
Editor: © SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria.
Copyright© SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. This article is available from url https://www.farmaceuticoscomunitarios.org/. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/
-
Manual for authors
Journal Information
Last update of farmaceuticoscomunitarios.org : 15.01.2025
Copyright © (Sociedad Española de Farmacia Clínica, Familiar y Comunitaria) |
ISSN Digital edition: 2173-9218
Journal committees - Legal notice - Privacy policy - Cookies policy - Advertising policy
e-mail: soporte@sefac.org | Responsible for this web site: Jordi Serrano Valdés
Development, Web design & computer programming: Edittec |
The information provided on this site is intended to complement and not to replace the
relation between a patient and his or her existing physician.
This work is under Creative Commons licence Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional licence.